COVID-19

COVID-19: Proactive Action Plan

Verona, Italy (25 February 2020) – In response to the news from the Italian Authorities, PM Holding Companies (CROS NT, Arithmos, seQure) are taking the following actions as a precautionary measure in our Italian offices with immediate effect: STAGE 1: Team Lead Mapping A complete mapping of staff, internal and external, has been done. For strategic…

Chief Commercial Officer Angela Weston

PM Holding Appoints Angela Weston as Chief Commercial Officer

Verona, Italy (11 September 2019) – PM Holding, a group of diverse service providers in the life sciences industry, announces the appointment of Angela Weston as Chief Commercial Officer to manage business development operations across the entire group. PM Holding consists of specialized service providers in the drug and device development sector including: CROS NT…

Sébastien_Gerin_Photo

CROS NT Appoints Sébastien Gerin as Chief Operating Officer

Verona, Italy (20 August 2019) – CROS NT announces that Sébastien Gerin has recently joined its global team in the role of Chief Operating Officer. Sébastien stepped into the new position this June as CROS NT continues to expand its global operations in terms of expert biometrics services and full service capacity in select geographic…

CROS NT_Data_Expertise_Clinical_Excellence

CROS NT Announces Extended Partnership with Medidata – Deploys RaveX

23 May 2017 (Maidenhead, UK and Chapel Hill, NC, USA) – CROS NT today announced go-live of its RaveX team in an extension of its partnership with Medidata. Under the partnership, CROS NT will offer its customers with RaveX—the latest generation of Medidata’s industry-leading EDC system, Medidata Rave®—as well as Medidata’s randomization and trial supply management…

Asthma

CROS NT Biostatisticians Co-Author Moderate Asthma Study Results in The Lancet Medical Journal

CROS NT’s Chairman, Paolo Morelli, and biostatistician, Marco Pannacci, are co-authors on a recent paper published in The Lancet Respiratory Medicine featuring the results of a moderate asthma clinical trial sponsored by the Italian Medicines Agency (AIFA). The full article can be found on the Lancet’s website. Paolo Morelli, given his statistical experience and background…

CROS NT Joins DATATRAK Connect™ Partner Program

CROS NT has expanded its life sciences technology portfolio by joining the DATATRAK Connect™ Program – a program which allows for extended service offerings for the drug development process with the goal of reducing study costs and furthering business development objectives. Under this partnership program, CROS NT can provide DATATRAK’s clinical trial technologies including Electronic…